Political economy of medical R&D and access: the case of Covid-19 vaccines
It is widely accepted that combating the COVID-19 pandemic requires a global collaborative effort and knowledge sharing to ease the development and distribution of new health technologies at affordable costs. However, in contrast, the world has witnessed the strengthening of Big Pharma companies together with "vaccine nationalism". While the rents of a few big pharmaceutical …
Political economy of medical R&D and access: the case of Covid-19 vaccines Read More »